Tag: EMPOWER CAD
EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days
Thirty-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneo...
EMPOWER CAD all-female IVL trial completes enrolment
Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective al...